The 54-year-old billionaire died, 600 million yuan of shares were not inherited, and Tsinghua graduated from an engineer to the vice president of the company

National Business Daily

2024-06-28 17:12The official account of National Business Daily

The full text is 1577 words, and it takes about 5 minutes to read

Highlight the point

01 Shenzhen Kaikai Biomedical Technology Co., Ltd. announced that Zhou Wenping, director and deputy general manager, died of illness at the age of 54, and shares worth 600 million yuan have not yet been inherited.

02 Zhou Wenping made unremitting efforts and important contributions to the company's development during his tenure as a director, member of the strategy committee, member of the remuneration and assessment committee, and deputy general manager of the company.

03Since Zhou Wenping's heirs have not yet handled matters related to share inheritance, the company will fulfill the follow-up information disclosure obligations in accordance with the requirements of relevant laws and regulations.

04According to the Articles of Association, the board of directors of the company is composed of 7 directors, and after the death of Zhou Wenping, the board of directors of the company was reduced to 6 people.

05The company's directors, supervisors, senior management and all employees will continue to be diligent and responsible, and are committed to the sustainable and steady development of the company.

Technical support is provided by Tencent Hybrid Model

On the evening of June 27, Shenzhen Kaikai Biomedical Technology Co., Ltd. (hereinafter referred to as Kaikai Medical, 300633.SZ) announced that Zhou Wenping, the company's director and deputy general manager, passed away due to illness recently. The Company and the Board of Directors extend their deep condolences to the passing away of Mr. Zhou Wenping and express their deep condolences to his family.

The 54-year-old billionaire died, 600 million yuan of shares were not inherited, and Tsinghua graduated from an engineer to the vice president of the company

Billionaire died at the age of 54

Shares worth 600 million yuan have not yet been inherited

Kaikai Medical said that during his tenure as a director, a member of the Strategy Committee, a member of the Remuneration and Assessment Committee, and a deputy general manager of the Company, Mr. Zhou Wenping fulfilled his duties, diligence and responsibilities, conscientiously fulfilled his duties and obligations, and made unremitting efforts and important contributions to the development of the Company. The Company and the Board of Directors would like to express their deep gratitude to Mr. Zhou Wenping for his efforts and contributions to the Company during his tenure.

It is worth noting that Kaikai Medical mentioned in the announcement that as of the date of this announcement, Mr. Zhou Wenping held 14,956,900 shares of the company (with a market value of about 600 million yuan as of the time of the announcement), with a shareholding ratio of 3.46%. Mr. Zhou Wenping's successor has not yet handled matters related to share inheritance, and the Company will fulfill the follow-up information disclosure obligations in accordance with the requirements of relevant laws and regulations.

According to the Articles of Association, the Board of Directors of the Company consists of 7 directors. After the death of Mr. Zhou Wenping, the number of members of the Board of Directors of the Company was reduced to 6, which was not lower than the minimum number of members of the Board of Directors stipulated in the Company Law. The Company will complete the by-election of directors as soon as possible in accordance with the relevant provisions of the Company Law and the Articles of Association. The directors, supervisors, senior management and all employees of the company will continue to be diligent and conscientious and committed to the sustainable and steady development of the company.

According to public information, Zhou Wenping, male, born in 1970, Chinese nationality, no right of permanent residence abroad, senior engineer. He graduated from Tsinghua University in 1992 with a bachelor's degree in biomedical engineering and instrumentation. From July 1992 to February 1993, he worked in Shantou Institute of Ultrasound Instruments; From February 1993 to February 1994, he worked as an engineer in the ultrasound product research and development department of Zhuhai Superman Company; From February 1994 to May 2002, he worked as a R&D engineer in Shantou Ultrasonic Instrument Research Institute; From May 2002 to December 2002, he served as an engineer in the ultrasound R&D department of Shenzhen Mindray Biomedical Electronics Co., Ltd.; Since December 2002, he has worked in Kaikai Medical, successively serving as manager of R&D department and deputy general manager. From 2005 to 2009, he served as a supervisor of Shenzhen Kaikai Biomedical Technology Co., Ltd. He is currently the director and deputy general manager of Kaikai Medical, and the executive director of Guangdong Ultrasound Medical Engineering Society.

The company's net profit in the first quarter was 100 million yuan

Two deputy general managers passed away within half a year

According to the official website, Shenzhen Kaikai Biomedical Technology Co., Ltd. (stock code: 300633) is a world-leading technology company, committed to the independent research and development and manufacturing of medical equipment, covering ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery and cardiovascular intervention, etc., providing professional and specialized overall solutions for medical institutions in more than 170 countries and regions around the world. The establishment of medical attaches great importance to technological innovation, and at the beginning of its establishment, it has simultaneously laid out overseas R&D centers. Up to now, it has set up seven R&D centers in San Francisco, Seattle, Tuttlingen, Tokyo, Japan, and Shenzhen, Shanghai, and Wuhan in China.

According to the financial report, in the first quarter of this year, Kaikai Medical achieved revenue of 479 million yuan, a year-on-year increase of 1.33%; net profit was 100 million yuan, down 27.65% year-on-year.

It is worth mentioning that two deputy general managers have passed away within half a year of opening the medical treatment. ACCORDING TO THE ANNOUNCEMENT, IN FEBRUARY THIS YEAR, ANOTHER DEPUTY GENERAL MANAGER OF THE COMPANY, JIANREN YUAN (YUAN JIANREN), ALSO PASSED AWAY DUE TO ILLNESS.

JIANRENYUAN, MALE, BORN IN 1947, AMERICAN NATIONALITY. In 1967, he graduated from Harbin Military Engineering Institute with a bachelor's degree in underwater acoustic physics. From 1985 to 1987, he studied for a master's degree in physics (acoustics) at the Catholic University of America. From 1987 to 1992, he studied for a Ph.D. in physics (acoustics) at the Catholic University of America. From 1968 to 1978, he served as the chief engineer of Shandong Zibo Radio No. 5 Factory; From 1981 to 1985, he served as the director of the Research Institute of Shandong Zibo Radio No. 5 Factory; From December 1992 to December 2000, he served as the chief engineer of Philips Medical Ultrasound System in the United States; From December 2000 to August 2010, he served as the manager and fellow of the R&D department of Boston Scientific Corporation (BSC) in the United States. From January 2001 to July 2010, he served as the chairman of Shanghai Aipec Electronic Technology Co., Ltd.; From August 2010 to December 2013, he served as the general manager of Philips Medical Systems Shanghai Aipec Electronic Technology Co., Ltd. He joined Kaikai Medical in 2014 and served as the deputy general manager of Kaikai Medical, the director and general manager of Shanghai Aisheng Biomedical Technology Co., Ltd. (a wholly-owned subsidiary of Kaikai Medical), and the director of Shenzhen Jinghui Investment Consulting Co., Ltd. (a shareholder of Kaikai Medical).

On June 28, the share price of Kaikai Medical fell sharply, down 3.72% as of the close, with a total market value of 17.127 billion yuan.

Editor|Duan Lian, Du Hengfeng, Du Bo

Proofreading|Sun Zhicheng

The daily economic news integrates self-opening medical announcements, opening medical official websites, Shenzhen Business Daily, public information, etc

View original image 216K